With the Migraine Research Foundation reporting that migraines affect 38 million people in the U.S. (more than diabetes and asthma put together), it's no surprise that First Choice Chiropractic & Rehab treats a lot of migraine patients in our Aloha, Beaverton office. While some folks try to relieve migraine pain with drugs, chiropractic care is a fantastic, all-natural choice that often produces positive results.
For instance, one report published in the Journal of Manipulative and Physiological Therapeutics involved 127 patients ranging in age from 10 to 70-years-old who struggled with regular (at least monthly) headaches. Each subject received up to 16 chiropractic sessions. The patients noted that their headache frequency, duration, and disability two months before the study began, during the duration of the sessions (which was two months), and two months post-treatment.
What the researchers discovered is that spinal manipulation therapy reduced the frequency, duration, and disability of the migraine pain when compared with the control group who didn't receive chiropractic. Even better, this allowed them to take less medication for the pain, offering them an all-natural solution for a chronic condition.
Another study found that a combination of chiropractic and neck massage reduced migraine headaches almost 68%.
If you have migraine headaches and are looking for relief, call First Choice Chiropractic & Rehab today and request an appointment in our Aloha, Beaverton chiropractic office. We'll do what we can to help you become pain-free!
Migraine Fact Sheet. Migraine Research Foundation. Retrieved from http://www.migraineresearchfoundation.org/fact-sheet.html on November 2, 2015
Noudeh Y et al. (2012). Reduction of current migraine headache pain following neck massage and spinal manipulation. International Journal of Therapeutic Massage & Bodywork;5(1):5-13
Tuchin P et al. (2000, February). A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. Journal of Manipulative and Physiological Therapeutics;23(2):91-5